401k Plan data: NEOS THERAPEUTICS 401(K) INVESTMENT PLAN plan

NEOS THERAPEUTICS 401(K) INVESTMENT PLAN 401k Plan overview

Plan Name	NEOS THERAPEUTICS 401(K) INVESTMENT PLAN
Plan identification number	002

NEOS THERAPEUTICS 401(K) INVESTMENT PLAN Benefits

401k Plan Type

Defined Contribution Pension

Plan Features/Benefits

Profit-sharing
ERISA section 404(c) Plan - This plan, or any part of it is intended to meet the conditions of 29 CFR 2550.404c-1.
Total participant-directed account plan - Participants have the opportunity to direct the investment of all the assets allocated to their individual accounts, regardless of whether 29 CFR 2550.404c-1 is intended to be met.
Code section 401(k) feature - A cash or deferred arrangement described in Code section 401(k) that is part of a qualified defined contribution plan that provides for an election by employees to defer part of their compensation or receive these amounts in cash.
Code section 401(m) arrangement - Employee contributions are allocated to separate accounts under the plan or employer contributions are based, in whole or in part, on employee deferrals or contribtions to the plan. Not applicable if plan is 401(k) plan with only QNECs and/or QMACs. Also not applicable if Code section 403(b)(1), 403(b)(7) or 408 arrangements/accounts/annuities.
Plan provides for automatic enrollment in plan that has employee contributions deducted from payroll.
Total or partial participant-directed account plan - plan uses default investment account for participants who fail to direct assets in their account.
Master plan - A pension plan that is made available by a sponsor for adoption by employers; that is the subject of a favorable opinion letter; and for which a single funding medium (for example, a trust or custodial account) is established for the joint use of all adopting employers.
Plan sponsor(s) is (are) a member(s) of a controlled group (Code sections 414(b), (c), or (m)).

401k Sponsoring company profile

NEOS THERAPEUTICS, LP has sponsored the creation of one or more 401k plans.

Company Name: NEOS THERAPEUTICS, LP

Employer identification number (EIN): 752822938

NAIC Classification: 325410

Additional information about NEOS THERAPEUTICS, LP

Jurisdiction of Incorporation: Texas Secretary of State

Incorporation Date: 1999-06-16

Company Identification Number: 0012158510

Legal Registered Office Address: 2940 N STATE HIGHWAY 360 STE 400

GRAND PRAIRIE
United States of America (USA)
75050

More information about NEOS THERAPEUTICS, LP

Form 5500 Filing Information

Submission information for form 5500 for 401k plan NEOS THERAPEUTICS 401(K) INVESTMENT PLAN

Plan id# Filing Submission Date Name of Administrator Date Administrator Signed Name of Company Sponsor Date Sponsor Signed
002 2021-01-01
002 2021-01-01 ARLEN EWART
002 2020-01-01
002 2019-01-01
002 2018-01-01
002 2017-01-01 ARLEN EWART
002 2016-01-01 ARLEN EWART
002 2015-01-01 ARLEN EWART
002 2014-01-01 ARLEN EWART
002 2013-01-01 ARLEN EWART
002 2012-01-01 ELLEN HOFFING
002 2011-01-01 ARLEN EWART
002 2009-01-01 MARK TENGLER

Plan Statistics for NEOS THERAPEUTICS 401(K) INVESTMENT PLAN

401k plan membership statisitcs for NEOS THERAPEUTICS 401(K) INVESTMENT PLAN

Measure Date Value
2021: NEOS THERAPEUTICS 401(K) INVESTMENT PLAN 2021 401k membership
Total participants, beginning-of-year 2021-01-01 236
Total number of active participants reported on line 7a of the Form 5500 2021-01-01 111
Number of retired or separated participants receiving benefits 2021-01-01 0
Number of other retired or separated participants entitled to future benefits 2021-01-01 84
Total of all active and inactive participants 2021-01-01 195
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2021-01-01 0
Total participants 2021-01-01 195
Number of participants with account balances 2021-01-01 185
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2021-01-01 0
2020: NEOS THERAPEUTICS 401(K) INVESTMENT PLAN 2020 401k membership
Total participants, beginning-of-year 2020-01-01 264
Total number of active participants reported on line 7a of the Form 5500 2020-01-01 147
Number of retired or separated participants receiving benefits 2020-01-01 0
Number of other retired or separated participants entitled to future benefits 2020-01-01 89
Total of all active and inactive participants 2020-01-01 236
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2020-01-01 0
Total participants 2020-01-01 236
Number of participants with account balances 2020-01-01 216
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2020-01-01 0
2019: NEOS THERAPEUTICS 401(K) INVESTMENT PLAN 2019 401k membership
Total participants, beginning-of-year 2019-01-01 281
Total number of active participants reported on line 7a of the Form 5500 2019-01-01 205
Number of retired or separated participants receiving benefits 2019-01-01 0
Number of other retired or separated participants entitled to future benefits 2019-01-01 58
Total of all active and inactive participants 2019-01-01 263
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2019-01-01 0
Total participants 2019-01-01 263
Number of participants with account balances 2019-01-01 227
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2019-01-01 0
2018: NEOS THERAPEUTICS 401(K) INVESTMENT PLAN 2018 401k membership
Total participants, beginning-of-year 2018-01-01 154
Total number of active participants reported on line 7a of the Form 5500 2018-01-01 210
Number of retired or separated participants receiving benefits 2018-01-01 0
Number of other retired or separated participants entitled to future benefits 2018-01-01 71
Total of all active and inactive participants 2018-01-01 281
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2018-01-01 0
Total participants 2018-01-01 281
Number of participants with account balances 2018-01-01 215
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2018-01-01 0
2017: NEOS THERAPEUTICS 401(K) INVESTMENT PLAN 2017 401k membership
Total participants, beginning-of-year 2017-01-01 154
Total number of active participants reported on line 7a of the Form 5500 2017-01-01 131
Number of retired or separated participants receiving benefits 2017-01-01 0
Number of other retired or separated participants entitled to future benefits 2017-01-01 23
Total of all active and inactive participants 2017-01-01 154
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2017-01-01 0
Total participants 2017-01-01 154
Number of participants with account balances 2017-01-01 123
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2017-01-01 0
2016: NEOS THERAPEUTICS 401(K) INVESTMENT PLAN 2016 401k membership
Total participants, beginning-of-year 2016-01-01 102
Total number of active participants reported on line 7a of the Form 5500 2016-01-01 132
Number of retired or separated participants receiving benefits 2016-01-01 0
Number of other retired or separated participants entitled to future benefits 2016-01-01 22
Total of all active and inactive participants 2016-01-01 154
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2016-01-01 0
Total participants 2016-01-01 154
Number of participants with account balances 2016-01-01 118
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2016-01-01 0
2015: NEOS THERAPEUTICS 401(K) INVESTMENT PLAN 2015 401k membership
Total participants, beginning-of-year 2015-01-01 78
Total number of active participants reported on line 7a of the Form 5500 2015-01-01 76
Number of retired or separated participants receiving benefits 2015-01-01 0
Number of other retired or separated participants entitled to future benefits 2015-01-01 26
Total of all active and inactive participants 2015-01-01 102
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2015-01-01 0
Total participants 2015-01-01 102
Number of participants with account balances 2015-01-01 82
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2015-01-01 2
2014: NEOS THERAPEUTICS 401(K) INVESTMENT PLAN 2014 401k membership
Total participants, beginning-of-year 2014-01-01 80
Total number of active participants reported on line 7a of the Form 5500 2014-01-01 48
Number of retired or separated participants receiving benefits 2014-01-01 0
Number of other retired or separated participants entitled to future benefits 2014-01-01 30
Total of all active and inactive participants 2014-01-01 78
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2014-01-01 0
Total participants 2014-01-01 78
Number of participants with account balances 2014-01-01 65
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2014-01-01 1
2013: NEOS THERAPEUTICS 401(K) INVESTMENT PLAN 2013 401k membership
Total participants, beginning-of-year 2013-01-01 90
Total number of active participants reported on line 7a of the Form 5500 2013-01-01 58
Number of retired or separated participants receiving benefits 2013-01-01 0
Number of other retired or separated participants entitled to future benefits 2013-01-01 22
Total of all active and inactive participants 2013-01-01 80
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2013-01-01 0
Total participants 2013-01-01 80
Number of participants with account balances 2013-01-01 66
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2013-01-01 6
2012: NEOS THERAPEUTICS 401(K) INVESTMENT PLAN 2012 401k membership
Total participants, beginning-of-year 2012-01-01 87
Total number of active participants reported on line 7a of the Form 5500 2012-01-01 65
Number of retired or separated participants receiving benefits 2012-01-01 0
Number of other retired or separated participants entitled to future benefits 2012-01-01 25
Total of all active and inactive participants 2012-01-01 90
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2012-01-01 0
Total participants 2012-01-01 90
Number of participants with account balances 2012-01-01 75
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2012-01-01 2
2011: NEOS THERAPEUTICS 401(K) INVESTMENT PLAN 2011 401k membership
Total participants, beginning-of-year 2011-01-01 93
Total number of active participants reported on line 7a of the Form 5500 2011-01-01 62
Number of retired or separated participants receiving benefits 2011-01-01 0
Number of other retired or separated participants entitled to future benefits 2011-01-01 25
Total of all active and inactive participants 2011-01-01 87
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2011-01-01 0
Total participants 2011-01-01 87
Number of participants with account balances 2011-01-01 66
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2011-01-01 2
2009: NEOS THERAPEUTICS 401(K) INVESTMENT PLAN 2009 401k membership
Total participants, beginning-of-year 2009-01-01 83
Total number of active participants reported on line 7a of the Form 5500 2009-01-01 39
Number of retired or separated participants receiving benefits 2009-01-01 0
Number of other retired or separated participants entitled to future benefits 2009-01-01 19
Total of all active and inactive participants 2009-01-01 58
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2009-01-01 0
Total participants 2009-01-01 58
Number of participants with account balances 2009-01-01 45
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2009-01-01 0

Measure	Date	Value
2021: NEOS THERAPEUTICS 401(K) INVESTMENT PLAN 2021 401k membership
Total participants, beginning-of-year	2021-01-01	236
Total number of active participants reported on line 7a of the Form 5500	2021-01-01	111
Number of retired or separated participants receiving benefits	2021-01-01	0
Number of other retired or separated participants entitled to future benefits	2021-01-01	84
Total of all active and inactive participants	2021-01-01	195
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2021-01-01	0
Total participants	2021-01-01	195
Number of participants with account balances	2021-01-01	185
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2021-01-01	0
2020: NEOS THERAPEUTICS 401(K) INVESTMENT PLAN 2020 401k membership
Total participants, beginning-of-year	2020-01-01	264
Total number of active participants reported on line 7a of the Form 5500	2020-01-01	147
Number of retired or separated participants receiving benefits	2020-01-01	0
Number of other retired or separated participants entitled to future benefits	2020-01-01	89
Total of all active and inactive participants	2020-01-01	236
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2020-01-01	0
Total participants	2020-01-01	236
Number of participants with account balances	2020-01-01	216
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2020-01-01	0
2019: NEOS THERAPEUTICS 401(K) INVESTMENT PLAN 2019 401k membership
Total participants, beginning-of-year	2019-01-01	281
Total number of active participants reported on line 7a of the Form 5500	2019-01-01	205
Number of retired or separated participants receiving benefits	2019-01-01	0
Number of other retired or separated participants entitled to future benefits	2019-01-01	58
Total of all active and inactive participants	2019-01-01	263
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2019-01-01	0
Total participants	2019-01-01	263
Number of participants with account balances	2019-01-01	227
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2019-01-01	0
2018: NEOS THERAPEUTICS 401(K) INVESTMENT PLAN 2018 401k membership
Total participants, beginning-of-year	2018-01-01	154
Total number of active participants reported on line 7a of the Form 5500	2018-01-01	210
Number of retired or separated participants receiving benefits	2018-01-01	0
Number of other retired or separated participants entitled to future benefits	2018-01-01	71
Total of all active and inactive participants	2018-01-01	281
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2018-01-01	0
Total participants	2018-01-01	281
Number of participants with account balances	2018-01-01	215
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2018-01-01	0
2017: NEOS THERAPEUTICS 401(K) INVESTMENT PLAN 2017 401k membership
Total participants, beginning-of-year	2017-01-01	154
Total number of active participants reported on line 7a of the Form 5500	2017-01-01	131
Number of retired or separated participants receiving benefits	2017-01-01	0
Number of other retired or separated participants entitled to future benefits	2017-01-01	23
Total of all active and inactive participants	2017-01-01	154
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2017-01-01	0
Total participants	2017-01-01	154
Number of participants with account balances	2017-01-01	123
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2017-01-01	0
2016: NEOS THERAPEUTICS 401(K) INVESTMENT PLAN 2016 401k membership
Total participants, beginning-of-year	2016-01-01	102
Total number of active participants reported on line 7a of the Form 5500	2016-01-01	132
Number of retired or separated participants receiving benefits	2016-01-01	0
Number of other retired or separated participants entitled to future benefits	2016-01-01	22
Total of all active and inactive participants	2016-01-01	154
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2016-01-01	0
Total participants	2016-01-01	154
Number of participants with account balances	2016-01-01	118
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2016-01-01	0
2015: NEOS THERAPEUTICS 401(K) INVESTMENT PLAN 2015 401k membership
Total participants, beginning-of-year	2015-01-01	78
Total number of active participants reported on line 7a of the Form 5500	2015-01-01	76
Number of retired or separated participants receiving benefits	2015-01-01	0
Number of other retired or separated participants entitled to future benefits	2015-01-01	26
Total of all active and inactive participants	2015-01-01	102
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2015-01-01	0
Total participants	2015-01-01	102
Number of participants with account balances	2015-01-01	82
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2015-01-01	2
2014: NEOS THERAPEUTICS 401(K) INVESTMENT PLAN 2014 401k membership
Total participants, beginning-of-year	2014-01-01	80
Total number of active participants reported on line 7a of the Form 5500	2014-01-01	48
Number of retired or separated participants receiving benefits	2014-01-01	0
Number of other retired or separated participants entitled to future benefits	2014-01-01	30
Total of all active and inactive participants	2014-01-01	78
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2014-01-01	0
Total participants	2014-01-01	78
Number of participants with account balances	2014-01-01	65
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2014-01-01	1
2013: NEOS THERAPEUTICS 401(K) INVESTMENT PLAN 2013 401k membership
Total participants, beginning-of-year	2013-01-01	90
Total number of active participants reported on line 7a of the Form 5500	2013-01-01	58
Number of retired or separated participants receiving benefits	2013-01-01	0
Number of other retired or separated participants entitled to future benefits	2013-01-01	22
Total of all active and inactive participants	2013-01-01	80
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2013-01-01	0
Total participants	2013-01-01	80
Number of participants with account balances	2013-01-01	66
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2013-01-01	6
2012: NEOS THERAPEUTICS 401(K) INVESTMENT PLAN 2012 401k membership
Total participants, beginning-of-year	2012-01-01	87
Total number of active participants reported on line 7a of the Form 5500	2012-01-01	65
Number of retired or separated participants receiving benefits	2012-01-01	0
Number of other retired or separated participants entitled to future benefits	2012-01-01	25
Total of all active and inactive participants	2012-01-01	90
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2012-01-01	0
Total participants	2012-01-01	90
Number of participants with account balances	2012-01-01	75
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2012-01-01	2
2011: NEOS THERAPEUTICS 401(K) INVESTMENT PLAN 2011 401k membership
Total participants, beginning-of-year	2011-01-01	93
Total number of active participants reported on line 7a of the Form 5500	2011-01-01	62
Number of retired or separated participants receiving benefits	2011-01-01	0
Number of other retired or separated participants entitled to future benefits	2011-01-01	25
Total of all active and inactive participants	2011-01-01	87
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2011-01-01	0
Total participants	2011-01-01	87
Number of participants with account balances	2011-01-01	66
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2011-01-01	2
2009: NEOS THERAPEUTICS 401(K) INVESTMENT PLAN 2009 401k membership
Total participants, beginning-of-year	2009-01-01	83
Total number of active participants reported on line 7a of the Form 5500	2009-01-01	39
Number of retired or separated participants receiving benefits	2009-01-01	0
Number of other retired or separated participants entitled to future benefits	2009-01-01	19
Total of all active and inactive participants	2009-01-01	58
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2009-01-01	0
Total participants	2009-01-01	58
Number of participants with account balances	2009-01-01	45
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2009-01-01	0

Financial Data on NEOS THERAPEUTICS 401(K) INVESTMENT PLAN

Measure	Date	Value
2021 : NEOS THERAPEUTICS 401(K) INVESTMENT PLAN 2021 401k financial data
Total unrealized appreciation/depreciation of assets	2021-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2021-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2021-12-31	$0
Total income from all sources (including contributions)	2021-12-31	$2,954,051
Total loss/gain on sale of assets	2021-12-31	$0
Total of all expenses incurred	2021-12-31	$2,500,956
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2021-12-31	$2,449,572
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2021-12-31	$1,300,143
Value of total assets at end of year	2021-12-31	$12,973,513
Value of total assets at beginning of year	2021-12-31	$12,520,418
Total of administrative expenses incurred including professional, contract, advisory and management fees	2021-12-31	$51,384
Total interest from all sources	2021-12-31	$6,997
Total dividends received (eg from common stock, registered investment company shares)	2021-12-31	$171,101
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2021-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2021-12-31	$171,101
Was this plan covered by a fidelity bond	2021-12-31	Yes
Value of fidelity bond cover	2021-12-31	$1,200,000
If this is an individual account plan, was there a blackout period	2021-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2021-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2021-12-31	No
Contributions received from participants	2021-12-31	$896,627
Participant contributions at end of year	2021-12-31	$151,654
Participant contributions at beginning of year	2021-12-31	$148,484
Participant contributions at end of year	2021-12-31	$0
Participant contributions at beginning of year	2021-12-31	$28,046
Income. Received or receivable in cash from other sources (including rollovers)	2021-12-31	$10,044
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2021-12-31	No
Value of net income/loss	2021-12-31	$453,095
Value of net assets at end of year (total assets less liabilities)	2021-12-31	$12,973,513
Value of net assets at beginning of year (total assets less liabilities)	2021-12-31	$12,520,418
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2021-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2021-12-31	No
Were any leases to which the plan was party in default or uncollectible	2021-12-31	No
Investment advisory and management fees	2021-12-31	$43,761
Value of interest in registered invesment companies (eg mutual funds) at end of year	2021-12-31	$12,478,665
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2021-12-31	$12,045,898
Interest on participant loans	2021-12-31	$6,020
Income. Interest from loans (other than to participants)	2021-12-31	$0
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2021-12-31	$343,194
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2021-12-31	$282,591
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2021-12-31	$282,591
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2021-12-31	$977
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2021-12-31	$1,475,810
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2021-12-31	No
Was there a failure to transmit to the plan any participant contributions	2021-12-31	No
Has the plan failed to provide any benefit when due under the plan	2021-12-31	No
Contributions received in cash from employer	2021-12-31	$393,472
Employer contributions (assets) at end of year	2021-12-31	$0
Employer contributions (assets) at beginning of year	2021-12-31	$15,399
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2021-12-31	$2,449,572
Contract administrator fees	2021-12-31	$7,623
Did the plan have assets held for investment	2021-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2021-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2021-12-31	No
Opinion of an independent qualified public accountant for this plan	2021-12-31	Unqualified
Accountancy firm name	2021-12-31	WEAVER AND TIDWELL, LLP
Accountancy firm EIN	2021-12-31	750786316
2020 : NEOS THERAPEUTICS 401(K) INVESTMENT PLAN 2020 401k financial data
Total unrealized appreciation/depreciation of assets	2020-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2020-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2020-12-31	$0
Total income from all sources (including contributions)	2020-12-31	$3,511,652
Total loss/gain on sale of assets	2020-12-31	$0
Total of all expenses incurred	2020-12-31	$2,139,055
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2020-12-31	$2,090,040
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2020-12-31	$1,824,467
Value of total assets at end of year	2020-12-31	$12,520,418
Value of total assets at beginning of year	2020-12-31	$11,147,821
Total of administrative expenses incurred including professional, contract, advisory and management fees	2020-12-31	$49,015
Total interest from all sources	2020-12-31	$7,334
Total dividends received (eg from common stock, registered investment company shares)	2020-12-31	$168,340
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2020-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2020-12-31	$168,340
Was this plan covered by a fidelity bond	2020-12-31	Yes
Value of fidelity bond cover	2020-12-31	$1,000,000
If this is an individual account plan, was there a blackout period	2020-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2020-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2020-12-31	No
Contributions received from participants	2020-12-31	$1,173,491
Participant contributions at end of year	2020-12-31	$148,484
Participant contributions at beginning of year	2020-12-31	$150,020
Participant contributions at end of year	2020-12-31	$28,046
Income. Received or receivable in cash from other sources (including rollovers)	2020-12-31	$117,903
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2020-12-31	No
Value of net income/loss	2020-12-31	$1,372,597
Value of net assets at end of year (total assets less liabilities)	2020-12-31	$12,520,418
Value of net assets at beginning of year (total assets less liabilities)	2020-12-31	$11,147,821
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2020-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2020-12-31	No
Were any leases to which the plan was party in default or uncollectible	2020-12-31	No
Investment advisory and management fees	2020-12-31	$43,510
Value of interest in registered invesment companies (eg mutual funds) at end of year	2020-12-31	$12,045,898
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2020-12-31	$10,893,003
Interest on participant loans	2020-12-31	$5,630
Income. Interest from loans (other than to participants)	2020-12-31	$0
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2020-12-31	$282,591
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2020-12-31	$104,279
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2020-12-31	$104,279
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2020-12-31	$1,704
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2020-12-31	$1,511,511
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2020-12-31	No
Was there a failure to transmit to the plan any participant contributions	2020-12-31	No
Has the plan failed to provide any benefit when due under the plan	2020-12-31	No
Contributions received in cash from employer	2020-12-31	$533,073
Employer contributions (assets) at end of year	2020-12-31	$15,399
Employer contributions (assets) at beginning of year	2020-12-31	$519
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2020-12-31	$2,090,040
Contract administrator fees	2020-12-31	$5,505
Did the plan have assets held for investment	2020-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2020-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2020-12-31	No
Opinion of an independent qualified public accountant for this plan	2020-12-31	Unqualified
Accountancy firm name	2020-12-31	WEAVER AND TIDWELL, LLP
Accountancy firm EIN	2020-12-31	750786316
2019 : NEOS THERAPEUTICS 401(K) INVESTMENT PLAN 2019 401k financial data
Total unrealized appreciation/depreciation of assets	2019-12-31	$0
Total unrealized appreciation/depreciation of assets	2019-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2019-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2019-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2019-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2019-12-31	$0
Total income from all sources (including contributions)	2019-12-31	$4,181,124
Total income from all sources (including contributions)	2019-12-31	$4,181,124
Total loss/gain on sale of assets	2019-12-31	$0
Total loss/gain on sale of assets	2019-12-31	$0
Total of all expenses incurred	2019-12-31	$1,747,860
Total of all expenses incurred	2019-12-31	$1,747,860
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2019-12-31	$1,701,362
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2019-12-31	$1,701,362
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2019-12-31	$2,068,512
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2019-12-31	$2,068,512
Value of total assets at end of year	2019-12-31	$11,147,821
Value of total assets at end of year	2019-12-31	$11,147,821
Value of total assets at beginning of year	2019-12-31	$8,714,557
Value of total assets at beginning of year	2019-12-31	$8,714,557
Total of administrative expenses incurred including professional, contract, advisory and management fees	2019-12-31	$46,498
Total of administrative expenses incurred including professional, contract, advisory and management fees	2019-12-31	$46,498
Total interest from all sources	2019-12-31	$8,893
Total interest from all sources	2019-12-31	$8,893
Total dividends received (eg from common stock, registered investment company shares)	2019-12-31	$612,538
Total dividends received (eg from common stock, registered investment company shares)	2019-12-31	$612,538
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2019-12-31	No
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2019-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2019-12-31	$612,538
Total dividends received from registered investment company shares (eg mutual funds)	2019-12-31	$612,538
Was this plan covered by a fidelity bond	2019-12-31	Yes
Was this plan covered by a fidelity bond	2019-12-31	Yes
Value of fidelity bond cover	2019-12-31	$1,000,000
Value of fidelity bond cover	2019-12-31	$1,000,000
If this is an individual account plan, was there a blackout period	2019-12-31	No
If this is an individual account plan, was there a blackout period	2019-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2019-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2019-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2019-12-31	No
Contributions received from participants	2019-12-31	$1,308,363
Contributions received from participants	2019-12-31	$1,308,363
Participant contributions at end of year	2019-12-31	$150,020
Participant contributions at end of year	2019-12-31	$150,020
Participant contributions at beginning of year	2019-12-31	$160,846
Participant contributions at beginning of year	2019-12-31	$160,846
Income. Received or receivable in cash from other sources (including rollovers)	2019-12-31	$183,303
Income. Received or receivable in cash from other sources (including rollovers)	2019-12-31	$183,303
Administrative expenses (other) incurred	2019-12-31	$23,972
Administrative expenses (other) incurred	2019-12-31	$23,972
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Value of net income/loss	2019-12-31	$2,433,264
Value of net income/loss	2019-12-31	$2,433,264
Value of net assets at end of year (total assets less liabilities)	2019-12-31	$11,147,821
Value of net assets at end of year (total assets less liabilities)	2019-12-31	$11,147,821
Value of net assets at beginning of year (total assets less liabilities)	2019-12-31	$8,714,557
Value of net assets at beginning of year (total assets less liabilities)	2019-12-31	$8,714,557
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2019-12-31	No
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2019-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2019-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2019-12-31	No
Were any leases to which the plan was party in default or uncollectible	2019-12-31	No
Were any leases to which the plan was party in default or uncollectible	2019-12-31	No
Investment advisory and management fees	2019-12-31	$19,008
Investment advisory and management fees	2019-12-31	$19,008
Value of interest in registered invesment companies (eg mutual funds) at end of year	2019-12-31	$10,893,003
Value of interest in registered invesment companies (eg mutual funds) at end of year	2019-12-31	$10,893,003
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2019-12-31	$8,367,700
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2019-12-31	$8,367,700
Interest on participant loans	2019-12-31	$11,646
Interest on participant loans	2019-12-31	$11,646
Income. Interest from loans (other than to participants)	2019-12-31	$0
Income. Interest from loans (other than to participants)	2019-12-31	$0
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2019-12-31	$104,279
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2019-12-31	$104,279
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2019-12-31	$186,011
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2019-12-31	$186,011
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2019-12-31	$186,011
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2019-12-31	$186,011
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2019-12-31	$-2,753
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2019-12-31	$-2,753
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2019-12-31	$1,491,181
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2019-12-31	$1,491,181
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2019-12-31	No
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2019-12-31	No
Was there a failure to transmit to the plan any participant contributions	2019-12-31	No
Was there a failure to transmit to the plan any participant contributions	2019-12-31	No
Has the plan failed to provide any benefit when due under the plan	2019-12-31	No
Has the plan failed to provide any benefit when due under the plan	2019-12-31	No
Contributions received in cash from employer	2019-12-31	$576,846
Contributions received in cash from employer	2019-12-31	$576,846
Employer contributions (assets) at end of year	2019-12-31	$519
Employer contributions (assets) at end of year	2019-12-31	$519
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2019-12-31	$1,701,362
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2019-12-31	$1,701,362
Contract administrator fees	2019-12-31	$3,518
Contract administrator fees	2019-12-31	$3,518
Did the plan have assets held for investment	2019-12-31	Yes
Did the plan have assets held for investment	2019-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2019-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2019-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2019-12-31	Yes
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2019-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2019-12-31	Disclaimer
Opinion of an independent qualified public accountant for this plan	2019-12-31	Disclaimer
Accountancy firm name	2019-12-31	WEAVER AND TIDWELL, LLP
Accountancy firm name	2019-12-31	WEAVER AND TIDWELL, LLP
Accountancy firm EIN	2019-12-31	750786316
Accountancy firm EIN	2019-12-31	750786316
2018 : NEOS THERAPEUTICS 401(K) INVESTMENT PLAN 2018 401k financial data
Unrealized appreciation/depreciation of real estate assets	2018-12-31	$0
Unrealized appreciation/depreciation of other (non real estate) assets	2018-12-31	$0
Total unrealized appreciation/depreciation of assets	2018-12-31	$0
Total transfer of assets to this plan	2018-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2018-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2018-12-31	$0
Expenses. Interest paid	2018-12-31	$0
Amount of participant contributions which was failed to transmit to the plan within the time period described in 29 CFR 251.3-102	2018-12-31	$0
Total income from all sources (including contributions)	2018-12-31	$1,883,050
Total loss/gain on sale of assets	2018-12-31	$0
Total of all expenses incurred	2018-12-31	$494,991
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2018-12-31	$452,340
Expenses. Certain deemed distributions of participant loans	2018-12-31	$0
Value of total corrective distributions	2018-12-31	$0
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2018-12-31	$2,549,058
Value of total assets at end of year	2018-12-31	$8,714,557
Value of total assets at beginning of year	2018-12-31	$7,326,498
Total of administrative expenses incurred including professional, contract, advisory and management fees	2018-12-31	$42,651
Total income from rents	2018-12-31	$0
Total interest from all sources	2018-12-31	$15,648
Total dividends received (eg from common stock, registered investment company shares)	2018-12-31	$732,895
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2018-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2018-12-31	$732,895
Assets. Real estate other than employer real property at end of year	2018-12-31	$0
Assets. Real estate other than employer real property at beginning of year	2018-12-31	$0
Administrative expenses professional fees incurred	2018-12-31	$0
Assets. Corporate prefeered stocks other than exployer securities at end of year	2018-12-31	$0
Assets. Corporate prefeered stocks other than exployer securities at beginning of year	2018-12-31	$0
Was this plan covered by a fidelity bond	2018-12-31	Yes
Value of fidelity bond cover	2018-12-31	$550,000
If this is an individual account plan, was there a blackout period	2018-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2018-12-31	No
Contributions received from participants	2018-12-31	$1,332,292
Participant contributions at end of year	2018-12-31	$160,846
Participant contributions at beginning of year	2018-12-31	$76,148
Participant contributions at end of year	2018-12-31	$0
Participant contributions at beginning of year	2018-12-31	$0
Assets. Other investments not covered elsewhere at end of year	2018-12-31	$0
Assets. Other investments not covered elsewhere at beginning of year	2018-12-31	$0
Income. Received or receivable in cash from other sources (including rollovers)	2018-12-31	$628,720
Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries)	2018-12-31	$0
Value of other receiveables (less allowance for doubtful accounts) at end of year	2018-12-31	$0
Value of other receiveables (less allowance for doubtful accounts) at beginning of year	2018-12-31	$0
Assets. Loans (other than to participants) at end of year	2018-12-31	$0
Assets. Loans (other than to participants) at beginning of year	2018-12-31	$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year	2018-12-31	$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year	2018-12-31	$0
Other income not declared elsewhere	2018-12-31	$0
Administrative expenses (other) incurred	2018-12-31	$42,651
Liabilities. Value of operating payables at end of year	2018-12-31	$0
Liabilities. Value of operating payables at beginning of year	2018-12-31	$0
Total non interest bearing cash at end of year	2018-12-31	$0
Total non interest bearing cash at beginning of year	2018-12-31	$0
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2018-12-31	No
Income. Non cash contributions	2018-12-31	$0
Value of net income/loss	2018-12-31	$1,388,059
Value of net assets at end of year (total assets less liabilities)	2018-12-31	$8,714,557
Value of net assets at beginning of year (total assets less liabilities)	2018-12-31	$7,326,498
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2018-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2018-12-31	No
Were any leases to which the plan was party in default or uncollectible	2018-12-31	No
Assets. partnership/joint venture interests at end of year	2018-12-31	$0
Assets. partnership/joint venture interests at beginning of year	2018-12-31	$0
Investment advisory and management fees	2018-12-31	$0
Value of interest in registered invesment companies (eg mutual funds) at end of year	2018-12-31	$8,367,700
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2018-12-31	$7,039,231
Value of interest in pooled separate accounts at end of year	2018-12-31	$0
Value of interest in pooled separate accounts at beginning of year	2018-12-31	$0
Interest on participant loans	2018-12-31	$9,604
Income. Interest from loans (other than to participants)	2018-12-31	$0
Interest earned on other investments	2018-12-31	$0
Income. Interest from US Government securities	2018-12-31	$0
Income. Interest from corporate debt instruments	2018-12-31	$0
Value of interest in master investment trust accounts at end of year	2018-12-31	$0
Value of interest in master investment trust accounts at beginning of year	2018-12-31	$0
Value of interest in common/collective trusts at end of year	2018-12-31	$0
Value of interest in common/collective trusts at beginning of year	2018-12-31	$0
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2018-12-31	$186,011
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2018-12-31	$211,119
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2018-12-31	$211,119
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2018-12-31	$6,044
Assets. Value of investments in 103.12 investment entities at end of year	2018-12-31	$0
Assets. Value of investments in 103.12 investment entities at beginning of year	2018-12-31	$0
Expenses. Payments to insurance carriers foe the provision of benefits	2018-12-31	$0
Asset value of US Government securities at end of year	2018-12-31	$0
Asset value of US Government securities at beginning of year	2018-12-31	$0
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2018-12-31	$-1,414,551
Net investment gain/loss from pooled separate accounts	2018-12-31	$0
Net investment gain or loss from common/collective trusts	2018-12-31	$0
Net gain/loss from 103.12 investment entities	2018-12-31	$0
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2018-12-31	No
Was there a failure to transmit to the plan any participant contributions	2018-12-31	No
Has the plan failed to provide any benefit when due under the plan	2018-12-31	No
Assets. Invements in employer securities at end of year	2018-12-31	$0
Assets. Invements in employer securities at beginning of year	2018-12-31	$0
Assets. Value of employer real property at end of year	2018-12-31	$0
Assets. Value of employer real property at beginning of year	2018-12-31	$0
Contributions received in cash from employer	2018-12-31	$588,046
Employer contributions (assets) at end of year	2018-12-31	$0
Employer contributions (assets) at beginning of year	2018-12-31	$0
Income. Dividends from preferred stock	2018-12-31	$0
Income. Dividends from common stock	2018-12-31	$0
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2018-12-31	$452,340
Asset. Corporate debt instrument preferred debt at end of year	2018-12-31	$0
Asset. Corporate debt instrument preferred debt at beginning of year	2018-12-31	$0
Asset. Corporate debt instrument debt (other) at end of year	2018-12-31	$0
Asset. Corporate debt instrument debt (other) at beginning of year	2018-12-31	$0
Contract administrator fees	2018-12-31	$0
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2018-12-31	No
Assets. Corporate common stocks other than exployer securities at end of year	2018-12-31	$0
Assets. Corporate common stocks other than exployer securities at beginning of year	2018-12-31	$0
Liabilities. Value of benefit claims payable at end of year	2018-12-31	$0
Liabilities. Value of benefit claims payable at beginning of year	2018-12-31	$0
Assets. Value of buildings and other operty used in plan operation at end of year	2018-12-31	$0
Assets. Value of buildings and other operty used in plan operation at beginning of year	2018-12-31	$0
Did the plan have assets held for investment	2018-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2018-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2018-12-31	No
Aggregate proceeds on sale of assets	2018-12-31	$0
Aggregate carrying amount (costs) on sale of assets	2018-12-31	$0
Liabilities. Value of acquisition indebtedness at end of year	2018-12-31	$0
Liabilities. Value of acquisition indebtedness at beginning of year	2018-12-31	$0
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2018-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2018-12-31	Disclaimer
Accountancy firm name	2018-12-31	WEAVER AND TIDWELL, LLP
Accountancy firm EIN	2018-12-31	750786316
2017 : NEOS THERAPEUTICS 401(K) INVESTMENT PLAN 2017 401k financial data
Unrealized appreciation/depreciation of real estate assets	2017-12-31	$0
Unrealized appreciation/depreciation of other (non real estate) assets	2017-12-31	$0
Total unrealized appreciation/depreciation of assets	2017-12-31	$0
Total transfer of assets to this plan	2017-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2017-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2017-12-31	$0
Expenses. Interest paid	2017-12-31	$0
Amount of participant contributions which was failed to transmit to the plan within the time period described in 29 CFR 251.3-102	2017-12-31	$0
Total income from all sources (including contributions)	2017-12-31	$3,172,018
Total loss/gain on sale of assets	2017-12-31	$0
Total of all expenses incurred	2017-12-31	$385,396
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2017-12-31	$362,774
Expenses. Certain deemed distributions of participant loans	2017-12-31	$0
Value of total corrective distributions	2017-12-31	$0
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2017-12-31	$2,222,761
Value of total assets at end of year	2017-12-31	$7,326,498
Value of total assets at beginning of year	2017-12-31	$4,539,876
Total of administrative expenses incurred including professional, contract, advisory and management fees	2017-12-31	$22,622
Total income from rents	2017-12-31	$0
Total interest from all sources	2017-12-31	$8,096
Total dividends received (eg from common stock, registered investment company shares)	2017-12-31	$363,836
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2017-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2017-12-31	$363,836
Assets. Real estate other than employer real property at end of year	2017-12-31	$0
Assets. Real estate other than employer real property at beginning of year	2017-12-31	$0
Administrative expenses professional fees incurred	2017-12-31	$0
Assets. Corporate prefeered stocks other than exployer securities at end of year	2017-12-31	$0
Assets. Corporate prefeered stocks other than exployer securities at beginning of year	2017-12-31	$0
Was this plan covered by a fidelity bond	2017-12-31	Yes
Value of fidelity bond cover	2017-12-31	$550,000
If this is an individual account plan, was there a blackout period	2017-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2017-12-31	No
Contributions received from participants	2017-12-31	$911,768
Participant contributions at end of year	2017-12-31	$76,148
Participant contributions at beginning of year	2017-12-31	$88,215
Participant contributions at end of year	2017-12-31	$0
Participant contributions at beginning of year	2017-12-31	$0
Assets. Other investments not covered elsewhere at end of year	2017-12-31	$0
Assets. Other investments not covered elsewhere at beginning of year	2017-12-31	$0
Income. Received or receivable in cash from other sources (including rollovers)	2017-12-31	$897,195
Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries)	2017-12-31	$0
Value of other receiveables (less allowance for doubtful accounts) at end of year	2017-12-31	$0
Value of other receiveables (less allowance for doubtful accounts) at beginning of year	2017-12-31	$0
Assets. Loans (other than to participants) at end of year	2017-12-31	$0
Assets. Loans (other than to participants) at beginning of year	2017-12-31	$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year	2017-12-31	$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year	2017-12-31	$0
Other income not declared elsewhere	2017-12-31	$0
Administrative expenses (other) incurred	2017-12-31	$22,622
Liabilities. Value of operating payables at end of year	2017-12-31	$0
Liabilities. Value of operating payables at beginning of year	2017-12-31	$0
Total non interest bearing cash at end of year	2017-12-31	$0
Total non interest bearing cash at beginning of year	2017-12-31	$0
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2017-12-31	No
Income. Non cash contributions	2017-12-31	$0
Value of net income/loss	2017-12-31	$2,786,622
Value of net assets at end of year (total assets less liabilities)	2017-12-31	$7,326,498
Value of net assets at beginning of year (total assets less liabilities)	2017-12-31	$4,539,876
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2017-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2017-12-31	No
Were any leases to which the plan was party in default or uncollectible	2017-12-31	No
Assets. partnership/joint venture interests at end of year	2017-12-31	$0
Assets. partnership/joint venture interests at beginning of year	2017-12-31	$0
Investment advisory and management fees	2017-12-31	$0
Value of interest in registered invesment companies (eg mutual funds) at end of year	2017-12-31	$7,039,231
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2017-12-31	$4,258,220
Value of interest in pooled separate accounts at end of year	2017-12-31	$0
Value of interest in pooled separate accounts at beginning of year	2017-12-31	$0
Interest on participant loans	2017-12-31	$6,693
Income. Interest from loans (other than to participants)	2017-12-31	$0
Interest earned on other investments	2017-12-31	$0
Income. Interest from US Government securities	2017-12-31	$0
Income. Interest from corporate debt instruments	2017-12-31	$0
Value of interest in master investment trust accounts at end of year	2017-12-31	$0
Value of interest in master investment trust accounts at beginning of year	2017-12-31	$0
Value of interest in common/collective trusts at end of year	2017-12-31	$0
Value of interest in common/collective trusts at beginning of year	2017-12-31	$0
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2017-12-31	$211,119
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2017-12-31	$193,441
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2017-12-31	$193,441
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2017-12-31	$1,403
Assets. Value of investments in 103.12 investment entities at end of year	2017-12-31	$0
Assets. Value of investments in 103.12 investment entities at beginning of year	2017-12-31	$0
Expenses. Payments to insurance carriers foe the provision of benefits	2017-12-31	$0
Asset value of US Government securities at end of year	2017-12-31	$0
Asset value of US Government securities at beginning of year	2017-12-31	$0
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2017-12-31	$577,325
Net investment gain/loss from pooled separate accounts	2017-12-31	$0
Net investment gain or loss from common/collective trusts	2017-12-31	$0
Net gain/loss from 103.12 investment entities	2017-12-31	$0
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2017-12-31	No
Was there a failure to transmit to the plan any participant contributions	2017-12-31	No
Has the plan failed to provide any benefit when due under the plan	2017-12-31	No
Assets. Invements in employer securities at end of year	2017-12-31	$0
Assets. Invements in employer securities at beginning of year	2017-12-31	$0
Assets. Value of employer real property at end of year	2017-12-31	$0
Assets. Value of employer real property at beginning of year	2017-12-31	$0
Contributions received in cash from employer	2017-12-31	$413,798
Employer contributions (assets) at end of year	2017-12-31	$0
Employer contributions (assets) at beginning of year	2017-12-31	$0
Income. Dividends from preferred stock	2017-12-31	$0
Income. Dividends from common stock	2017-12-31	$0
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2017-12-31	$362,774
Asset. Corporate debt instrument preferred debt at end of year	2017-12-31	$0
Asset. Corporate debt instrument preferred debt at beginning of year	2017-12-31	$0
Asset. Corporate debt instrument debt (other) at end of year	2017-12-31	$0
Asset. Corporate debt instrument debt (other) at beginning of year	2017-12-31	$0
Contract administrator fees	2017-12-31	$0
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2017-12-31	No
Assets. Corporate common stocks other than exployer securities at end of year	2017-12-31	$0
Assets. Corporate common stocks other than exployer securities at beginning of year	2017-12-31	$0
Liabilities. Value of benefit claims payable at end of year	2017-12-31	$0
Liabilities. Value of benefit claims payable at beginning of year	2017-12-31	$0
Assets. Value of buildings and other operty used in plan operation at end of year	2017-12-31	$0
Assets. Value of buildings and other operty used in plan operation at beginning of year	2017-12-31	$0
Did the plan have assets held for investment	2017-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2017-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2017-12-31	No
Aggregate proceeds on sale of assets	2017-12-31	$0
Aggregate carrying amount (costs) on sale of assets	2017-12-31	$0
Liabilities. Value of acquisition indebtedness at end of year	2017-12-31	$0
Liabilities. Value of acquisition indebtedness at beginning of year	2017-12-31	$0
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2017-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2017-12-31	Disclaimer
Accountancy firm name	2017-12-31	WEAVER AND TIDWELL, LLC
Accountancy firm EIN	2017-12-31	750786316
2016 : NEOS THERAPEUTICS 401(K) INVESTMENT PLAN 2016 401k financial data
Transfers to/from the plan	2016-12-31	$0
Total plan liabilities at end of year	2016-12-31	$0
Total plan liabilities at beginning of year	2016-12-31	$0
Total income from all sources	2016-12-31	$1,890,301
Expenses. Total of all expenses incurred	2016-12-31	$719,199
Benefits paid (including direct rollovers)	2016-12-31	$684,863
Total plan assets at end of year	2016-12-31	$4,539,876
Total plan assets at beginning of year	2016-12-31	$3,368,774
Value of fidelity bond covering the plan	2016-12-31	$550,000
Total contributions received or receivable from participants	2016-12-31	$755,883
Expenses. Other expenses not covered elsewhere	2016-12-31	$0
Contributions received from other sources (not participants or employers)	2016-12-31	$441,514
Other income received	2016-12-31	$323,478
Noncash contributions received	2016-12-31	$0
Net income (gross income less expenses)	2016-12-31	$1,171,102
Net plan assets at end of year (total assets less liabilities)	2016-12-31	$4,539,876
Net plan assets at beginning of year (total assets less liabilities)	2016-12-31	$3,368,774
Assets. Value of participant loans	2016-12-31	$88,215
Value of participant contributions where there was a failure to transmit these to the plan within the time period described in 29 CFR 2510.3-102	2016-12-31	$0
Total contributions received or receivable from employer(s)	2016-12-31	$369,426
Value of certain deemed distributions of participant loans	2016-12-31	$3,231
Value of corrective distributions	2016-12-31	$10,698
Expenses. Administrative service providers (salaries,fees and commissions)	2016-12-31	$20,407
2015 : NEOS THERAPEUTICS 401(K) INVESTMENT PLAN 2015 401k financial data
Transfers to/from the plan	2015-12-31	$0
Total plan liabilities at end of year	2015-12-31	$0
Total plan liabilities at beginning of year	2015-12-31	$0
Total income from all sources	2015-12-31	$672,980
Expenses. Total of all expenses incurred	2015-12-31	$118,974
Benefits paid (including direct rollovers)	2015-12-31	$102,303
Total plan assets at end of year	2015-12-31	$3,368,774
Total plan assets at beginning of year	2015-12-31	$2,814,768
Value of fidelity bond covering the plan	2015-12-31	$350,000
Total contributions received or receivable from participants	2015-12-31	$389,391
Expenses. Other expenses not covered elsewhere	2015-12-31	$0
Contributions received from other sources (not participants or employers)	2015-12-31	$46,264
Other income received	2015-12-31	$-20,157
Noncash contributions received	2015-12-31	$0
Net income (gross income less expenses)	2015-12-31	$554,006
Net plan assets at end of year (total assets less liabilities)	2015-12-31	$3,368,774
Net plan assets at beginning of year (total assets less liabilities)	2015-12-31	$2,814,768
Assets. Value of participant loans	2015-12-31	$77,432
Value of participant contributions where there was a failure to transmit these to the plan within the time period described in 29 CFR 2510.3-102	2015-12-31	$0
Total contributions received or receivable from employer(s)	2015-12-31	$257,482
Value of certain deemed distributions of participant loans	2015-12-31	$0
Value of corrective distributions	2015-12-31	$0
Expenses. Administrative service providers (salaries,fees and commissions)	2015-12-31	$16,671
2014 : NEOS THERAPEUTICS 401(K) INVESTMENT PLAN 2014 401k financial data
Transfers to/from the plan	2014-12-31	$0
Total plan liabilities at end of year	2014-12-31	$0
Total plan liabilities at beginning of year	2014-12-31	$0
Total income from all sources	2014-12-31	$547,967
Expenses. Total of all expenses incurred	2014-12-31	$450,070
Benefits paid (including direct rollovers)	2014-12-31	$415,816
Total plan assets at end of year	2014-12-31	$2,814,768
Total plan assets at beginning of year	2014-12-31	$2,716,871
Value of fidelity bond covering the plan	2014-12-31	$265,000
Total contributions received or receivable from participants	2014-12-31	$317,447
Expenses. Other expenses not covered elsewhere	2014-12-31	$0
Contributions received from other sources (not participants or employers)	2014-12-31	$1,645
Other income received	2014-12-31	$137,234
Noncash contributions received	2014-12-31	$0
Net income (gross income less expenses)	2014-12-31	$97,897
Net plan assets at end of year (total assets less liabilities)	2014-12-31	$2,814,768
Net plan assets at beginning of year (total assets less liabilities)	2014-12-31	$2,716,871
Assets. Value of participant loans	2014-12-31	$42,232
Total contributions received or receivable from employer(s)	2014-12-31	$91,641
Value of certain deemed distributions of participant loans	2014-12-31	$0
Value of corrective distributions	2014-12-31	$19,446
Expenses. Administrative service providers (salaries,fees and commissions)	2014-12-31	$14,808
2013 : NEOS THERAPEUTICS 401(K) INVESTMENT PLAN 2013 401k financial data
Transfers to/from the plan	2013-12-31	$0
Total plan liabilities at end of year	2013-12-31	$0
Total income from all sources	2013-12-31	$1,077,631
Expenses. Total of all expenses incurred	2013-12-31	$374,687
Benefits paid (including direct rollovers)	2013-12-31	$364,106
Total plan assets at end of year	2013-12-31	$2,716,871
Total plan assets at beginning of year	2013-12-31	$2,013,927
Value of fidelity bond covering the plan	2013-12-31	$265,000
Total contributions received or receivable from participants	2013-12-31	$329,446
Expenses. Other expenses not covered elsewhere	2013-12-31	$0
Contributions received from other sources (not participants or employers)	2013-12-31	$283,458
Other income received	2013-12-31	$374,140
Noncash contributions received	2013-12-31	$0
Net income (gross income less expenses)	2013-12-31	$702,944
Net plan assets at end of year (total assets less liabilities)	2013-12-31	$2,716,871
Net plan assets at beginning of year (total assets less liabilities)	2013-12-31	$2,013,927
Assets. Value of participant loans	2013-12-31	$54,484
Total contributions received or receivable from employer(s)	2013-12-31	$90,587
Value of certain deemed distributions of participant loans	2013-12-31	$0
Value of corrective distributions	2013-12-31	$0
Expenses. Administrative service providers (salaries,fees and commissions)	2013-12-31	$10,581
2012 : NEOS THERAPEUTICS 401(K) INVESTMENT PLAN 2012 401k financial data
Total income from all sources	2012-12-31	$588,903
Expenses. Total of all expenses incurred	2012-12-31	$117,408
Benefits paid (including direct rollovers)	2012-12-31	$115,206
Total plan assets at end of year	2012-12-31	$2,013,927
Total plan assets at beginning of year	2012-12-31	$1,542,432
Value of fidelity bond covering the plan	2012-12-31	$265,000
Total contributions received or receivable from participants	2012-12-31	$286,959
Contributions received from other sources (not participants or employers)	2012-12-31	$22,780
Other income received	2012-12-31	$196,526
Net income (gross income less expenses)	2012-12-31	$471,495
Net plan assets at end of year (total assets less liabilities)	2012-12-31	$2,013,927
Net plan assets at beginning of year (total assets less liabilities)	2012-12-31	$1,542,432
Assets. Value of participant loans	2012-12-31	$29,206
Total contributions received or receivable from employer(s)	2012-12-31	$82,638
Value of corrective distributions	2012-12-31	$1,819
Expenses. Administrative service providers (salaries,fees and commissions)	2012-12-31	$383
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2012-12-31	$0
2011 : NEOS THERAPEUTICS 401(K) INVESTMENT PLAN 2011 401k financial data
Total income from all sources	2011-12-31	$185,859
Expenses. Total of all expenses incurred	2011-12-31	$56,422
Benefits paid (including direct rollovers)	2011-12-31	$55,346
Total plan assets at end of year	2011-12-31	$1,542,432
Total plan assets at beginning of year	2011-12-31	$1,412,995
Value of fidelity bond covering the plan	2011-12-31	$265,000
Total contributions received or receivable from participants	2011-12-31	$221,197
Other income received	2011-12-31	$-71,859
Net income (gross income less expenses)	2011-12-31	$129,437
Net plan assets at end of year (total assets less liabilities)	2011-12-31	$1,542,432
Net plan assets at beginning of year (total assets less liabilities)	2011-12-31	$1,412,995
Assets. Value of participant loans	2011-12-31	$57,277
Total contributions received or receivable from employer(s)	2011-12-31	$36,521
Value of corrective distributions	2011-12-31	$278
Expenses. Administrative service providers (salaries,fees and commissions)	2011-12-31	$798
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2011-12-31	$0
2010 : NEOS THERAPEUTICS 401(K) INVESTMENT PLAN 2010 401k financial data
Total income from all sources	2010-12-31	$341,308
Expenses. Total of all expenses incurred	2010-12-31	$52,171
Benefits paid (including direct rollovers)	2010-12-31	$40,442
Total plan assets at end of year	2010-12-31	$1,412,995
Total plan assets at beginning of year	2010-12-31	$1,123,858
Value of fidelity bond covering the plan	2010-12-31	$265,000
Total contributions received or receivable from participants	2010-12-31	$176,286
Other income received	2010-12-31	$161,056
Net income (gross income less expenses)	2010-12-31	$289,137
Net plan assets at end of year (total assets less liabilities)	2010-12-31	$1,412,995
Net plan assets at beginning of year (total assets less liabilities)	2010-12-31	$1,123,858
Assets. Value of participant loans	2010-12-31	$69,644
Total contributions received or receivable from employer(s)	2010-12-31	$3,966
Value of corrective distributions	2010-12-31	$10,943
Expenses. Administrative service providers (salaries,fees and commissions)	2010-12-31	$786
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2010-12-31	$0
2009 : NEOS THERAPEUTICS 401(K) INVESTMENT PLAN 2009 401k financial data
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2009-12-31	$0

Form 5500 Responses for NEOS THERAPEUTICS 401(K) INVESTMENT PLAN

2021: NEOS THERAPEUTICS 401(K) INVESTMENT PLAN 2021 form 5500 responses
2021-01-01	Type of plan entity	Single employer plan
2021-01-01	Submission has been amended	No
2021-01-01	This submission is the final filing	No
2021-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2021-01-01	Plan is a collectively bargained plan	No
2021-01-01	Plan funding arrangement – Trust	Yes
2021-01-01	Plan benefit arrangement - Trust	Yes
2020: NEOS THERAPEUTICS 401(K) INVESTMENT PLAN 2020 form 5500 responses
2020-01-01	Type of plan entity	Single employer plan
2020-01-01	Submission has been amended	No
2020-01-01	This submission is the final filing	No
2020-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2020-01-01	Plan is a collectively bargained plan	No
2020-01-01	Plan funding arrangement – Trust	Yes
2020-01-01	Plan benefit arrangement - Trust	Yes
2019: NEOS THERAPEUTICS 401(K) INVESTMENT PLAN 2019 form 5500 responses
2019-01-01	Type of plan entity	Single employer plan
2019-01-01	Submission has been amended	No
2019-01-01	This submission is the final filing	No
2019-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2019-01-01	Plan is a collectively bargained plan	No
2019-01-01	Plan funding arrangement – Trust	Yes
2019-01-01	Plan benefit arrangement - Trust	Yes
2018: NEOS THERAPEUTICS 401(K) INVESTMENT PLAN 2018 form 5500 responses
2018-01-01	Type of plan entity	Single employer plan
2018-01-01	Submission has been amended	No
2018-01-01	This submission is the final filing	No
2018-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2018-01-01	Plan is a collectively bargained plan	No
2018-01-01	Plan funding arrangement – Trust	Yes
2018-01-01	Plan benefit arrangement - Trust	Yes
2017: NEOS THERAPEUTICS 401(K) INVESTMENT PLAN 2017 form 5500 responses
2017-01-01	Type of plan entity	Single employer plan
2017-01-01	Submission has been amended	No
2017-01-01	This submission is the final filing	No
2017-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2017-01-01	Plan is a collectively bargained plan	No
2017-01-01	Plan funding arrangement – Trust	Yes
2017-01-01	Plan benefit arrangement - Trust	Yes
2016: NEOS THERAPEUTICS 401(K) INVESTMENT PLAN 2016 form 5500 responses
2016-01-01	Type of plan entity	Single employer plan
2016-01-01	Submission has been amended	No
2016-01-01	This submission is the final filing	No
2016-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2016-01-01	Plan is a collectively bargained plan	No
2016-01-01	Plan funding arrangement – Trust	Yes
2016-01-01	Plan benefit arrangement - Trust	Yes
2015: NEOS THERAPEUTICS 401(K) INVESTMENT PLAN 2015 form 5500 responses
2015-01-01	Type of plan entity	Single employer plan
2015-01-01	Submission has been amended	No
2015-01-01	This submission is the final filing	No
2015-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2015-01-01	Plan is a collectively bargained plan	No
2015-01-01	Plan funding arrangement – Trust	Yes
2015-01-01	Plan benefit arrangement - Trust	Yes
2014: NEOS THERAPEUTICS 401(K) INVESTMENT PLAN 2014 form 5500 responses
2014-01-01	Type of plan entity	Single employer plan
2014-01-01	Submission has been amended	No
2014-01-01	This submission is the final filing	No
2014-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2014-01-01	Plan is a collectively bargained plan	No
2014-01-01	Plan funding arrangement – Trust	Yes
2014-01-01	Plan benefit arrangement - Trust	Yes
2013: NEOS THERAPEUTICS 401(K) INVESTMENT PLAN 2013 form 5500 responses
2013-01-01	Type of plan entity	Single employer plan
2013-01-01	Submission has been amended	No
2013-01-01	This submission is the final filing	No
2013-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2013-01-01	Plan is a collectively bargained plan	No
2013-01-01	Plan funding arrangement – Trust	Yes
2013-01-01	Plan benefit arrangement - Trust	Yes
2012: NEOS THERAPEUTICS 401(K) INVESTMENT PLAN 2012 form 5500 responses
2012-01-01	Type of plan entity	Single employer plan
2012-01-01	Submission has been amended	No
2012-01-01	This submission is the final filing	No
2012-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2012-01-01	Plan funding arrangement – Trust	Yes
2012-01-01	Plan benefit arrangement - Trust	Yes
2011: NEOS THERAPEUTICS 401(K) INVESTMENT PLAN 2011 form 5500 responses
2011-01-01	Type of plan entity	Single employer plan
2011-01-01	Submission has been amended	No
2011-01-01	This submission is the final filing	No
2011-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2011-01-01	Plan funding arrangement – Trust	Yes
2011-01-01	Plan benefit arrangement - Trust	Yes
2009: NEOS THERAPEUTICS 401(K) INVESTMENT PLAN 2009 form 5500 responses
2009-01-01	Type of plan entity	Single employer plan
2009-01-01	Submission has been amended	No
2009-01-01	This submission is the final filing	No
2009-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2009-01-01	Plan funding arrangement – Trust	Yes
2009-01-01	Plan benefit arrangement - Trust	Yes

Was this data useful?

If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. By linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. Please use the share buttons. It will only take a few seconds of your time. Thanks for helping

Information Disclaimer

The information provided on this website is not advice, endorsement or recommendation
The information published is supplied by third parties so we make no warranty on the accuracy, completeness etc. This information is provided "as-is". The information is subject to change as we obtain updates and corrections from the primary information sources.
You are free to use the information for your own personal research on the understanding to do so is at your own risk.

See full terms and conditions

Company Name:	NEOS THERAPEUTICS, LP
Employer identification number (EIN):	752822938
NAIC Classification:	325410

Jurisdiction of Incorporation:	Texas Secretary of State
Incorporation Date:	1999-06-16
Company Identification Number:	0012158510
Legal Registered Office Address:	2940 N STATE HIGHWAY 360 STE 400 GRAND PRAIRIE United States of America (USA) 75050

Plan id#	Filing Submission Date	Name of Administrator
002	2021-01-01
002	2021-01-01	ARLEN EWART
002	2020-01-01
002	2019-01-01
002	2018-01-01
002	2017-01-01	ARLEN EWART
002	2016-01-01	ARLEN EWART
002	2015-01-01	ARLEN EWART
002	2014-01-01	ARLEN EWART
002	2013-01-01	ARLEN EWART
002	2012-01-01	ELLEN HOFFING
002	2011-01-01	ARLEN EWART
002	2009-01-01	MARK TENGLER